Rare diseases
Investigational molecules
Locations
Back to Austria2 clinical trials in Schwarzach Im Pongau, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
AustriaAustriaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on ischemic stroke prevention through innovative therapeutic approaches. The studies evaluate new treatments for patients who have experienced acute non-cardioembolic strokes or high-risk transient ischemic attacks.
The research investigates oral anticoagulation treatments combined with antiplatelet therapy, aiming to enhance protective measures against future stroke events.
Advanced studies in blood clot prevention are being conducted, specifically examining new compounds that target specific clotting factors. The research aims to improve outcomes for patients who have experienced mini-strokes.
Researchers are evaluating the effectiveness of new therapeutic agents while carefully monitoring bleeding risk factors.
Comprehensive research into transient ischemic attacks and their management, focusing on innovative preventive measures. The studies examine both immediate and long-term treatment strategies.
The research aims to establish more effective protocols for patients at high risk of recurring cerebrovascular events.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
